Back | Next |
home / stock / ccxi / ccxi message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CCXI News Article - ChemoCentryx Appoints Rita I. Jain, M.D. as Executive Vice Preside | whytestocks | investorshangout | 10/11/2021 12:50:52 PM |
I just started learning them. Actually seems like | rynlrt | investorshub | 10/09/2021 9:24:51 PM |
Guarantee next week they do an offering to | rynlrt | investorshub | 10/09/2021 9:23:54 PM |
Is that drop based on any TA? IMO | newdmontheblock | investorshub | 10/09/2021 6:17:59 AM |
$CCXI - Friday Rundown, Monday Expectations | Jake L | investorshub | 10/09/2021 3:53:17 AM |
J L: CCXI - Friday Rundown, Monday Expectations https://youtu.be/NCnKuBZS3fc | J L | investorshangout | 10/09/2021 3:51:21 AM |
This post aged well! | Cosa | investorshub | 10/09/2021 1:44:39 AM |
Cheers! | Cosa | investorshub | 10/09/2021 1:42:43 AM |
Nice work! | BoilerRoom | investorshub | 10/09/2021 12:17:33 AM |
I need to learn options. Sound fun | BoilerRoom | investorshub | 10/09/2021 12:17:09 AM |
znewcar1: CCXI 95% v145M c38.41 f69,9M gap S@28.8 HOD40.9 | znewcar1 | investorshangout | 10/08/2021 10:07:29 PM |
Got a short position?:) | mikebennett16 | investorshub | 10/08/2021 9:06:51 PM |
$CCXI Debt $71.7M | BottomBounce | investorshub | 10/08/2021 8:57:45 PM |
Up or down the last 30 minutes? Fear | jonnyvs | investorshub | 10/08/2021 7:34:32 PM |
Great video to end our trading session. Enjoy | crudeoil24 | investorshub | 10/08/2021 7:21:48 PM |
lol.......https://www.youtube.com/watch?v=2cZ EFAmj08 | Mikey | investorshub | 10/08/2021 7:12:06 PM |
ALL OUT .90, 1.00, 1.10.......from .30.....didnt maximize, but | Mikey | investorshub | 10/08/2021 7:09:07 PM |
I might........up quite a bit, eh? | Mikey | investorshub | 10/08/2021 7:00:12 PM |
take profits before this tanks $3-$8 on Monday | Nebuchadnezzar | investorshub | 10/08/2021 6:57:50 PM |
40.54 | crudeoil24 | investorshub | 10/08/2021 6:37:52 PM |
News, Short Squeeze, Breakout and More Instantly...
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX PR Newswire TAVNEOS ® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif. , Oct. 20, ...
-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS ® (avacopan) for patients with ANCA-associated vasculitis; additional poster will cover expression of kidney C5aR -- SAN CARLOS, Calif., Oct. 17,...
-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), tod...